Search results for "opioid receptor"

showing 6 items of 46 documents

Synthetic studies on neoclerodane diterpenes from Salvia splendens: oxidative modifications of ring A.

2011

Salvinorin A (1), a neoclerodane diterpene from the hallucinogenic mint Salvia divinorum, is the only known naturally occurring non-nitrogenous and specific κ-opioid agonist. Some oxidative modifications of the A ring in the congeners of 1 isolated from Salvia splendens salviarin, splenolide B, splendidin and in the non-natural 8-epi-salviarin gave new derivatives, some of which were tested as agonists at opioid receptors. However, none of these compounds were active. The presence of the C-18, C-19 lactone could be at the origin of the observed lack of binding affinity.

chemistry.chemical_classificationbiologyStereochemistryOrganic ChemistryPharmacognosySalviabiology.organism_classificationBiochemistryTerpenoidSalvinorin AArticleTerpenechemistry.chemical_compoundchemistryDrug DiscoverySalvia divinorumSalvia splendens. Opioid receptors. Neoclerodane diterpenes. Semisynthetic derivativesDiterpeneLactoneTetrahedron
researchProduct

SY26-4REVIEWING THE NEUROBIOLOGICAL EFFECTS OF SALSOLINOL: ROLE OF THE MU OPIOID RECEPTORS

2015

During the last decades Salsolinol (SAL), a condensation product from dopamine (DA) and acetaldehyde that appears in the brain of humans and rodents as a consequence of brain metabolism of ethanol, has been proposed as a key component in the development of alcohol use disorders. Although evidence has been published …

chemistry.chemical_compoundEthanolchemistryDopamineAcetaldehydemedicineSocial roleGeneral Medicineμ-opioid receptorPharmacologyPsychologyNeurosciencemedicine.drugAlcohol and Alcoholism
researchProduct

The Life Cycle of the Mu-Opioid Receptor

2020

Opioid receptors (ORs) are undisputed targets for the treatment of pain. Unfortunately, targeting these receptors therapeutically poses significant challenges including addiction, dependence, tolerance, and the appearance of side effects, such as respiratory depression and constipation. Moreover, misuse of prescription and illicit narcotics has resulted in the current opioid crisis. The mu-opioid receptor (MOR) is the cellular mediator of the effects of most commonly used opioids, and is a prototypical G protein-coupled receptor (GPCR) where new pharmacological, signalling and cell biology concepts have been coined. This review summarises the knowledge of the life cycle of this therapeutic …

media_common.quotation_subjectBioinformaticsBiochemistry03 medical and health sciences0302 clinical medicineMediatorAnimalsMedicineReceptorMolecular Biology030304 developmental biologymedia_commonG protein-coupled receptorLife Cycle Stages0303 health sciencesbusiness.industryAddictionDrug ToleranceAnalgesics OpioidOpioidReceptors Opioidμ-opioid receptorbusiness030217 neurology & neurosurgeryBiogenesismedicine.drugTrends in Biochemical Sciences
researchProduct

Exercise-induced euphoria and anxiolysis do not depend on endogenous opioids in humans

2021

Abstract A runner's high describes a sense of well-being during endurance exercise characterized by euphoria and anxiolysis. It has been a widespread belief that the release of endogenous opioids, such as endorphins, underlie a runner's high. However, exercise leads to the release of two classes of rewarding molecules, endocannabinoids (eCBs) and opioids. In mice, we have shown that core features of a runner's high depend on cannabinoid receptors but not opioid receptors. In the present study, we aimed to corroborate in humans that endorphins do not play a significant role in the underlying mechanism of a runner's high. Thus, we investigated whether the development of two core features of a…

medicine.medical_specialtyCannabinoid receptormedicine.drug_classEndocrinology Diabetes and MetabolismEuphoriantNaltrexoneRunningMice03 medical and health sciences0302 clinical medicineEndocrinologyOpioid receptorInternal medicineAnimalsHumansMedicineEndorphinsBiological PsychiatryEndogenous opioidEndocrine and Autonomic Systemsbusiness.industryEuphoria030227 psychiatryPsychiatry and Mental healthEndocrinologyOpioidAnxietyEndorphinsmedicine.symptombusinesshuman activities030217 neurology & neurosurgerymedicine.drugPsychoneuroendocrinology
researchProduct

Effects of Different Opioid Receptor Antagonists on the Electrically-Evoked Release of Endogenous Dopamine from the Isolated Neural Lobe of the Rat P…

2009

Abstract Isolated neural lobes of the rat pituitary gland were incubated in Krebs-HEPES solution which contained the dopamine uptake inhibitor GBR 12921 and in some experiments additionally pargyline. The release of endogenous dopamine evoked by electrical stimulation of the pituitary stalk was determined by high-performance liquid chromatography with electrochemical detection. (+/-)- Naloxone increased the evoked dopamine release maximally by 440% (EC(50) 209 nM). The (+)-enantiomer of naloxone (up to 10 muM) did not affect the release of dopamine. The preferential kappa-opioid receptor antagonist MR 2266 increased the evoked dopamine release maximally by 135% (EC(50) 7 nM). MR 2267, the i…

medicine.medical_specialtyEndocrine and Autonomic SystemsChemistrymedicine.drug_classEndocrinology Diabetes and Metabolism(+)-NaloxonePharmacologyCellular and Molecular NeuroscienceEndocrinologyEndocrinologyDopamine receptor D1Dopamine receptorOpioid receptorDopamineInternal medicineDopamine receptor D2medicineEndogenous agonistEndogenous opioidmedicine.drugJournal of neuroendocrinology
researchProduct

Synthesis and Structure-Affinity Relationships of Spirocyclic Benzopyrans with Exocyclic Amino Moiety

2019

σ1 and/or σ2 receptors play a crucial role in pathological conditions such as pain, neurodegenerative disorders, and cancer. A set of spirocyclic cyclohexanes with diverse O-heterocycles and amino moieties (general structure III) was prepared and pharmacologically evaluated. In structure-activity relationships studies, the σ1 receptor affinity and σ1:σ2 selectivity were correlated with the stereochemistry, the kind and substitution pattern of the O-heterocycle, and the substituents at the exocyclic amino moiety. cis-configured 2-benzopyran cis-11b bearing a methoxy group and a tertiary cyclohexylmethylamino moiety showed the highest σ1 affinity ( Ki = 1.9 nM) of this series of compounds. In…

synthesisexocyclic amino moietyReceptors Opioid mudocking studieCrystallography X-RayLigands01 natural sciencesopioid receptorschemistry.chemical_compoundProtein structureDrug DiscoveryMoiety0303 health sciencesσ1 receptor ligandsstructure (σ1) affinity relationshipmolecular dynamicBenzyl groupMolecular MedicinesynthesiBenzopyransSelectivityHydrophobic and Hydrophilic Interactionsfree binding enthalpyStereochemistrychange of receptor profileMolecular Dynamics Simulation03 medical and health sciencesStructure-Activity Relationshipσ1 receptor ligands; spirocyclic compounds; benzopyrans; benzofurans; exocyclic amino moiety; synthesis; structure (σ1) affinity relationships; σ1 antagonistic activity; receptor selectivity; molecular dynamics; docking studies; free binding enthalpy; X-ray crystal structure; opioid receptors; MOR affinity; change of receptor profile; structure MOR affinity relationshipsstructure (σ1) affinity relationshipsStructure–activity relationshipHumansReceptors sigmaBenzopyransSpiro Compoundsspirocyclic compoundBinding siteMOR affinity030304 developmental biologybenzopyranbenzofuransσ1 receptor ligandBinding Sitesspirocyclic compoundsreceptor selectivitystructure MOR affinity relationshipsdocking studiesbenzofuranopioid receptorX-ray crystal structuremolecular dynamics0104 chemical sciencesProtein Structure Tertiary010404 medicinal & biomolecular chemistrychemistrySalt bridgeσ1 antagonistic activity
researchProduct